# Rhythm Pharmaceuticals Inc. (RYTM) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$192M |
| 2024 | -$266M |
| 2023 | -$184M |
| 2022 | -$179M |
| 2021 | -$170M |
| 2020 | -$137M |
| 2019 | -$146M |
| 2018 | -$78M |
| 2017 | -$32M |
| 2016 | -$26M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$52M |
| 2025-09-30 | -$53M |
| 2025-06-30 | -$45M |
| 2025-03-31 | -$47M |
| 2024-09-30 | -$44M |
| 2024-06-30 | -$40M |
| 2024-03-31 | -$140M |
| 2023-09-30 | -$44M |
| 2023-06-30 | -$47M |
| 2023-03-31 | -$53M |
| 2022-09-30 | -$39M |
| 2022-06-30 | -$45M |
| 2022-03-31 | -$53M |
| 2021-09-30 | -$44M |
| 2021-06-30 | -$40M |
| 2021-03-31 | -$34M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/RYTM/operating-income)